Thank you, Mr. Chair.
In 2016, at hearings of the committee, Dr. Bonnie Henry, the provincial health officer for British Columbia, said that detoxification programs for users of opioids were not working, because the physiological dependence created by opioids required opioid substitution therapy, based on products like Suboxone. There was also discussion of Vivitrol at the hearings.
All of that led to recommendation 21 in a committee report, which I believe was adopted unanimously.
The recommendation reads as follows:
That the Government of Canada improve access to medications for opioid addiction treatment such as Suboxone® and other effective medications not currently available in Canada, especially for people at high risk of complication and death.
In British Columbia, do you have data on the number of substitution therapies, access to these substitution therapies, and their efficacy in terms of medium-term recovery?